Irinotecan and bevacizumab in recurrent glioblastoma multiforme

By Jakobsen Jan Nyrop   Hasselbalch Benedikte   Stockhausen Marie-Thééréése   Lassen Ulrik   Poulsen Hans Skovgaard  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 825-833

Informa Healthcare

Access to resources Recommend Favorite

Novel chemotherapeutic agents for the treatment of glioblastoma multiforme

By Jendrossek Verena   Belka Claus   Bamberg Michael  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1899-1924

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenesis Treatment for Glioblastoma Multiforme: Challenges and Opportunities

By Wong Eric T.   Brem Steven  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 5, 2008-05 ,pp. : 515-522

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

By Chang Susan   Wen Patrick   Cloughesy Timothy   Greenberg Harry   Schiff David   Conrad Charles   Fink Karen   Robins H.   Angelis Lisa   Raizer Jeffrey   Hess Kenneth   Aldape Ken   Lamborn Kathleen   Kuhn John   Dancey Janet   Prados Michael  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 357-361

Springer Publishing Company

Access to resources Recommend Favorite